« Previous
Next »
The Journal of Allergy and Clinical Immunology
Volume 124, Issue 1
, Pages
45-51.e4
, July 2009
Airway remodeling in subjects with severe asthma with or without chronic persistent airflow obstruction
-
ASM in endobronchial biopsy specimens. Smooth muscle bundles (shown in brown) are larger in a subject with chronic persistent obstruction (B) than in a subject with intermittent obstruction (A). C, Is
ASM in endobronchial biopsy specimens. Smooth muscle bundles (shown in brown) are larger in a subject with chronic persistent obstruction (B) than in a subject with intermittent obstruction (A). C, Isotype control (α-smooth muscle actin immunoperoxidase staining).
-
Correlation between SMA (percentage of total biopsy area) and FEV1 (percent predicted) in subjects with severe asthma. Solid triangles, Subjects with chronic persistent obstruction; open triangles, suCorrelation between SMA (percentage of total biopsy area) and FEV1 (percent predicted) in subjects with severe asthma. Solid triangles, Subjects with chronic persistent obstruction; open triangles, subjects with intermittent obstruction.
-
Correlation between Pi10 (a measure of airway wall thickness on HRCT, see the Methods section for details) and RBM thickness (A) and SMA % (B) for 13 subjects who underwent HRCT and a biopsy and betweCorrelation between Pi10 (a measure of airway wall thickness on HRCT, see the Methods section for details) and RBM thickness (A) and SMA % (B) for 13 subjects who underwent HRCT and a biopsy and between Pi10 and FEV1 percent predicted (from the study visit closest to HRCT; n = 21; C).
Supported by the Richard and Edith Strauss Canada Foundation, Canadian Institutes of Health Research.
Disclosure of potential conflict of interest: H. Coxson has served as a consultant/advisor board member for GlaxoSmithKline and has received research support fro GlaxoSmithKline, Spiration, and Wyeth. C. Lemière has received research support from the National Institute for Occupational Safety and Health and the Institut de Recherche Robert-Sauvé en Santé et Sécurité du Travail and has served as an advisor to GlaxoSmithKline, AstraZeneca, and Novartis. P. Ernst has received speaker's fees from or served on an advisory board for AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Merck, Novartis, and Nycomed. Q. Hamid has received research support from the McGill University Health Center Strauss Foundation. The rest of the authors have declared that they have no conflict of interest.
PII: S0091-6749(09)00637-X
doi: 10.1016/j.jaci.2009.03.049
© 2009 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
The Journal of Allergy and Clinical Immunology
Volume 124, Issue 1
, Pages
45-51.e4
, July 2009
